4//SEC Filing
Donaldson Michael Paul 4
Accession 0000921895-21-000543
CIK 0001599298other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:59 PM ET
Size
6.2 KB
Accession
0000921895-21-000543
Insider Transaction Report
Form 4
Donaldson Michael Paul
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2021-02-19−5,110→ 594,890 totalExercise: $3.52Exp: 2030-06-08→ Common Stock (5,110 underlying)
Footnotes (3)
- [F1]Represents the forfeiture of performance-based stock options granted to the Reporting Person on June 8, 2020 that were eligible to vest based on certain performance conditions. Upon grant, the target vesting amount was reported in Table II of Form 3. On February 19, 2021, the Compensation Committee of the Board of Directors of the Issuer determined that, based on the Issuer's performance over the applicable performance period, 37,129 shares would vest and 5,110 shares would be forfeited.
- [F2]As of February 19, 2021, a total of 79,368 shares have vested and 515,522 shares remain eligible to vest from this grant.
- [F3]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001824022
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:59 PM ET
- Size
- 6.2 KB